Covance

What it does

Covance (now Labcorp Drug Development) is one of the world's largest contract research organizations (CROs) - providing end-to-end drug development services from early discovery through regulatory approval. AI capabilities include AI-powered patient recruitment analytics that identify optimal trial sites and predict enrollment rates, ML biomarker analysis that identifies patient subpopulations most likely to respond to investigational drugs, automated safety signal detection in clinical trial data, AI-assisted regulatory submission writing that drafts clinical study reports from structured trial data, and predictive trial timeline modeling that forecasts schedule risk. Covance combines its CRO service capabilities with AI tools that improve trial efficiency, reduce timelines, and increase probability of regulatory success.

Strengths

• Pharmaceutical companies and biotech firms use Covance for outsourced drug development - AI-enhanced CRO services improving clinical trial efficiency, accelerating regulatory submissions, and reducing development timelines.
• Covance (now Labcorp Drug Development) is one of the world's largest contract research organizations (CROs) - providing end-to-end drug development services from early discovery through regulatory approval.
• AI capabilities include AI-powered patient recruitment analytics that identify optimal trial sites and predict enrollment rates, ML biomarker analysis that identifies patient subpopulations most likely to respond to investigational drugs, automated safety signal detection in clinical trial data, AI-assisted regulatory submission writing that drafts clinical study reports from structured trial data, and predictive trial timeline modeling that forecasts schedule risk.

Watch-outs

• CRO services, not software product: Covance is a contract research organization providing services — pharmaceutical companies seeking self-service clinical trial software rather than outsourced CRO services need dedicated clinical trial technology platforms.
• Enterprise pharmaceutical clients only: Covance's minimum project scale and pricing reflect enterprise pharmaceutical development programs — early-stage biotechs and academic researchers typically engage smaller, more flexible CROs for early phase work.
• AI capabilities embedded in services, not standalone: Covance's AI tools are components of its service delivery rather than standalone platform products — clients cannot independently access or configure the AI models outside Covance's service engagement.

Pricing

Covance clinical trial services priced per-study based on scope, indication, phase, and number of sites. Early phase studies from hundreds of thousands to millions. Late phase pivotal trials run tens to hundreds of millions. Negotiated contracts.